Anxo Pharmaceutical Co., Ltd.

Anxo Pharmaceutical Co., Ltd.

6677.TWO
Anxo Pharmaceutical Co., Ltd.TW flagTaipei Exchange
17.10
TWD
-0.60
- -
957.26MMarket Cap

Anxo Pharmaceutical Co., Ltd. (6677.TWO) Stock Split History

Learn about Anxo Pharmaceutical Co., Ltd.'s most recent 259-for-250 basis stock split on July 11, 2023. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Anxo Pharmaceutical Co., Ltd.'s most recent stock split

Split Date: 2023-07-11
Split Ratio: 259:250
Price Before Split: $65.58
Price After Split: $63.30

Developer API

Get 6677.TWO split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/6677.TWO

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.04 times more shares (a 259:250 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Anxo Pharmaceutical Co., Ltd.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-07-11259:250No$65.58$63.30
2021-11-0121:20No$25.18$23.98
2019-07-15103:100No$35.14$34.11

About Anxo Pharmaceutical Co., Ltd.

Company overview and industry information

Anxo Pharmaceutical Co., Ltd. (6677.TWO) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 259-for-250 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Drug Manufacturers - Specialty & Generic
Go to Anxo Pharmaceutical Co., Ltd. Summary

Last updated: 7/6/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.